Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Khalid Najib

Interventional Cardiology South Bend, IN Medical Doctor

NPI 1558626077 CMS profile 1005667

610 N Michigan St Ste 400, South Bend, IN 46601

Open in the dashboard

General payments

$26,477

235 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Khalid Najib of South Bend, IN is reported in the CMS Open Payments database as having received $26,477 across 235 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $915 20
2024 General $1,979 10
2023 General $5,880 91
2022 General $13,492 68
2021 General $2,719 25
2020 General $748 9
2019 General $742 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Khalid Najib
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Khalid Najib were reported at $915. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Khalid Najib Interventional Cardiology median Middle half National median
2019 $742 $1,097 $329–$3,048 $163
2020 $748 $473 $161–$1,480 $114
2021 $2,719 $677 $233–$1,827 $132
2022 $13,492 $978 $333–$2,724 $149
2023 $5,880 $1,136 $382–$2,986 $160
2024 $1,979 $1,181 $395–$3,326 $164
2025 $915 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $12,161 34 payments
  2. Abbott Laboratories $3,244 36 payments
  3. Edwards Lifesciences Corporation $2,146 49 payments
  4. Penumbra, Inc. $2,048 11 payments
  5. Boston Scientific Corporation $1,031 11 payments
  6. Cardiovascular Systems Inc. $928 8 payments
  7. Philips Electronics North America Corporation $866 6 payments
  8. Inari Medical, Inc. $682 6 payments
  9. Cook Incorporated $616 3 payments
  10. Abiomed $530 8 payments
  11. Other $2,225 63 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $10,621 3 payments
  2. Food and Beverage $8,853 189 payments
  3. Travel and Lodging $6,027 34 payments
  4. Education $926 8 payments
  5. Gift $50 1 payment
Products named General payments · program years 2019–2025
  1. Indigo System $2,011 9 payments
  2. COREVALVE EVOLUT R $1,633 21 payments
  3. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $1,065 21 payments
  4. Perclose ProStyle $1,025 1 payment
  5. Zilver PTX $1,004 7 payments
  6. (7881) US Und $836 5 payments
  7. FLOWTRIEVER CATHETER, S $753 7 payments
  8. Diamondback Peripheral $688 6 payments
  9. SAPIEN 3 Ultra RESILIA $617 13 payments
  10. CT THROMBECTOMY SYSTEM KIT $611 5 payments
  11. Other $6,674 151 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Interventional Cardiology: 2,236

Drug cost

$88

Median for Interventional Cardiology: $380,412

Branded share of claims

0%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Atorvastatin Calcium Generic 13 $88

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$42,220

Medicare's payments for the services billed

Medicare patients

145

Average age 75

Services billed

536

76 women, 69 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 69%
Heart failure 66%
Arthritis 64%
Diabetes 54%
Chronic kidney disease 54%
Atrial fibrillation 52%
COPD 48%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

235 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record